key: cord-0273294-k3fre2kx
authors: Lučiūnaitė, Asta; Dalgėdienė, Indrė; Žilionis, Rapolas; Mašalaitė, Kristina; Norkienė, Milda; Šinkūnas, Andrius; Gedvilaitė, Alma; Kučinskaitė-Kodzė, Indrė; Žvirblienė, Aurelija
title: Activation of NLRP3 Inflammasome by Virus-like Particles of Human Polyomaviruses in Macrophages
date: 2021-11-15
journal: bioRxiv
DOI: 10.1101/2021.11.15.468577
sha: aae492dcecc4cfe0dc55f3797b61fee8e26e97cf
doc_id: 273294
cord_uid: k3fre2kx

Viral antigens can activate phagocytes inducing inflammation but the mechanisms are barely explored. This study aimed to investigate the capability of viral oligomeric proteins of different structure to induce inflammatory response in macrophages. Human THP-1 cell line was used to prepare macrophages which were treated with filamentous nucleocapsid-like particles (NLPs) of paramyxoviruses and spherical virus-like particles (VLPs) of human polyomaviruses. The effects of viral proteins on cell viability, pro-inflammatory cytokines’ production and formation of NLRP3 inflammasome components, ASC specks, were investigated. Filamentous NLPs did not induce inflammation markers while spherical VLPs mediated inflammatory response followed by NLRP3 inflammasome activation. Inhibitors of cathepsins and K+ efflux decreased IL-1β levels and cell death indicating a complex inflammasome activation process. Similar activation pattern was observed in primary human macrophages treated with VLPs. Single cell RNAseq analysis of THP-1 cells revealed several cell activation states characterized by high expression of inflammation-related genes. This study provides new insights into interaction of viral proteins with innate immune cells and suggests that structural properties of oligomeric proteins may define cell activation pathways.

The components of innate immunity such as macrophages play a key role in the onset 30 and progression of inflammatory and age-related diseases (Oishi & Manabe, 2016; Parisi et 31 al, 2018) . Macrophages are considered as a potential target for treatment of many diseases, 32 therefore, molecular mechanisms related to their activation is currently at the top of research 33 . Besides, macrophages are known to recognize the structural properties of 34 the activation agents and influence the inflammatory response via inflammasome activation 35 (Rabolli et al, 2016a; Shu & Shi, 2018) . Inflammasomes are intracellular protein complexes 36

representing important components of the innate immune system (de Alba, 2019). The best 37 described representative is NLRP3 inflammasome. It contains three major components -38

nucleotide-binding and oligomerization domain-like receptor, apoptosis-associated speck-like 39 protein containing CARD (ASC) and pro-caspase-1. NLRP3 inflammasome assembly results 40

in IL-1β release and inflammatory cell deathpyroptosis (Swanson et al, 2019) . Endogenous 41 and external factors can trigger its assembly. Its assembly can be triggered by endogenous 42 and external factors. Activation of NLRP3 inflammasome is associated with various diseases, 43

including gout and Alzheimer's disease (Fusco et al, 2020) . Our previous study showed that 44 NLRP3 inflammasome is activated by amyloid beta (Aβ), both oligomers and protofibrils 45 (Luciunaite et al) . Inflammasome activation was also induced by α-synuclein (Codolo et al, 46 2013), and tau oligomers (Ising et al, 2019) . However, the most explored inflammasome 47 triggers are polymeric nanoparticles (Doshi & Mitragotri, 2010) , cholesterol crystals 48 (Samstad et al, 2014) , airborne pollutants such as silica (Dostert et al, 2008) . The structural 49

properties of synthetic nanoparticles determine the outcome of cell activation (Baranov et al, 50 2020) . Previously, we have demonstrated that spherical oligomeric proteins of viral origin 51 induce inflammatory responses in macrophages but the mechanism and molecular 52 components of this process are not yet confirmed (Dalgediene et al, 2018) . In addition, 53 another study demonstrated that the nucleocapsid (N) protein of Zika virus activated the 54 inflammasome (Wang et al, 2018) . Repetitive and latent viral infections are potential agents 55 of inflammation (Maloney et al, 2013) . This frame of reference draws attention to the latent 56 viral infections and their role in inflammation. 57

It is well known that some viruses lie dormant within the host after an acute infection. 58

According to World Health Organisation, 50-80% of world population is infected by 59 polyomaviruses (PyVs) in the childhood (De Gascun & Carr, 2013). The effects of these 60 viruses and their antigens on innate immunity throughout the life are not fully understood. 61

For example, herpes virus in its latent form can cause multisymptom illness with a broad 62 range of simultaneous symptoms, such as cognitive disorders, depression, fatigue (Maloney 63 et al., 2013) . However, the mechanism of multisymptomatic illness is unclear. Investigation 64 of inflammatory responses induced by proteins of viruses causing acute and latent infection 65 may indicate whether these viral proteins alone are capable of activating the immune system. 66

Moreover, VLPs are already established as carriers and adjuvants in vaccines. Components of 67

vaccines can activate the inflammasome as it was reported for the ISCOMATRIX adjuvant 68 (Wilson et al, 2014) . Studying how different viral proteins especially VLPs stimulate the 69 immune cells would allow the selection of better tools for vaccination. 70

Inflammatory reactions induced by synthetic polymeric particles in macrophages vary 71

depending on their size and shape (Shu & Shi, 2018; Rabolli, 2016) . Similarly, viral proteins 72 may also fate cellular response depending on their structural properties. Our study was aimed 73

to investigate how recombinant viral proteins induce inflammatory response in macrophages 74

focusing on inflammasome activation. The VLPs derived from major capsid protein VP1 of 75 human PyVs -Karolinska Institute (KI) PyV and Merkel cell (MC) PyV, self-assembling to 76 spherical particles about 20-60 nm in diameter (Norkiene et al, 2015b) , were selected as 77 typical representatives of spherical oligomeric proteins. The NLPs of measles and mumps 78 viruses were chosen as a model of oligomeric proteins forming filamentous rod-shaped 79

structures (Samuel et al, 2003; Zvirbliene et al, 2007) . We showed that inflammatory 80 responses and activation of NLRP3 inflammasome in macrophages depend on the structural 81

properties of viral proteins. This study provides new insights on the ability of multimeric 82 viral antigens to induce inflammatory response in innate immune cells. 83

We investigated the ability of viral multimeric proteins to induce inflammatory 85 response in macrophages focusing on inflammasome activation. For this study, we have 86 selected structurally diverse viral proteins: filamentous NLPs of measles and mumps viruses 87 (Paramyxoviridae family) that usually cause acute infections, and spherical VLPs derived 88 from VP1 of PyVs (Polyomaviridae family) that generally induce latent viral infections. We 89 (Fig 3D-F) and IL-1β release showing inflammasome activation (Fig 3C) . Pre-treatment with 132 MCC950 inhibitor before adding the VLPs significantly decreased this activation signal ( Fig  133  3C -F). The inhibitor MCC950 did not influence the secretion level of other inflammatory 134 cytokine TNF-α showing the specificity of inhibitor to inflammasome activation (Fig 3A) . 135 These data demonstrate that PyV-derived VLPs are potent inflammatory agents triggering 136 inflammatory cytokine secretion and pyroptotic cell death. 137

In the next step, we investigated the formation of ASC specks that would indicate the 138 assembly of the inflammasome. To detect ASC specks, we used THP-1-ASC-GFP 139 macrophages. We identified ASC specks after treating cells with PyV-derived VLPs (Fig 4) . 140

However, MCC950 did not fully inhibit ASC speck formation (Fig 4B) , which might be 141 explained by ASC speck release from the inflammasome-activated cells. Secreted ASC 142 specks can promote further maturation of inflammatory cytokines (Franklin et al, 2018) . In 143 addition, ASC specks could induce a subsequent inflammatory response by activating the 144 surrounding cells. 145

Next, we performed time-lapse experiments to observe the dynamics of cell activation 146

by PyV-derived VLPs. We measured LDH release in wild-type THP-1 cells treated with 147

PyV-derived VLPs for 15-23 h. There were no differences in LDH release within this time 148 interval ( Fig 4C) . We also took the fluorescent microscopy images of THP-1-ASC-GFP after 149

14-24 h treatment with VLPs. Again, we did not find considerable differences within the 14-150 24 h treatment period ( Fig 4D) . All cells were similar according to fluorescence intensity. We 151 concluded that THP-1 macrophages are activated at about 15 h after VLP addition and their 152 activation pattern remains constant from this time point. 153

To prove VLP-induced activation of the inflammasome, we assayed for active 154 caspase-1, which is a major component of the inflammasome cascade, converting pro-IL-1β 155 to its mature form. Having the time lapse experiment data, we collected cell culture 156 supernatant for caspase-1 assay after 15 hfrom the steady cell activation time point in order 157 not to lose the active enzyme. The cleaved caspase-1 p20 fragment was immunodetected by 158 WB after THP-1 treatment with VLPs ( Fig 5A) . NLRP3 inhibitor MCC950 reduced 159 generation of the activated caspase-1. Then, we analysed caspase-1 activation at a single-cell 160 level using FLICA reagent. It contains FAM-YVAD-FMK caspase-1 inhibitor probe, which 161 covalently binds to only activated caspase-1. We revealed caspase-1 activation in some THP-162 1 macrophages after treatment with PyV-derived VLPs (Fig 5B) . Large-sized MCPyV-163 derived VLPs induced a stronger response as compared to KIPyV-derived VLPs. 164 Inflammasome inhibitor MCC950 reduced the level of activated caspase-1. We also stained 165 VLP-treated cell cultures with PI to identify dead cells. Activated caspase-1 co-localised with 166 dead cells confirming the pyroptotic cell death. Therefore, we concluded that PyV-derived 167

VLPs induce inflammasome activation. 168

The mechanism of VLP-mediated inflammasome activation is related to lysosomal 169 damage 170

We further investigated the mechanism of inflammasome activation by PyV-derived 171

VLPs. It is likely that accumulation of phagocytosed VLPs in lysosomes can damage them 172

and induce the release of cathepsins, in particular cathepsin B (CtsB) that is one of the 173 activators of NLRP3 inflammasome. We observed a significant decrease of IL-1β secretion 174 after treatment of THP-1 cells with CtsB inhibitor Ca-074 Me ( Fig 6A) . However, CtsB did 175 not reduce cell death (Fig 6B and C) . The results were the same even at higher (10 µM) Ca-176 074 Me concentration (Fig 6D and E) . This suggests that VLPs may induce the cytotoxicity 177 by different mechanism next to lysosomal damage-associated cell death. 178

Then, we treated THP-1 cells with the pan-cathepsins inhibitor K777. We observed a 179 significant decrease in cell death (Fig 6F-H) . Staining of cell nuclei with PI to count dead 180 cells confirmed that K777 inhibitor protected from cell death. Next, we measured IL-1β 181 release and found that K777 significantly suppressed IL-1β secretion, however, not to control 182

baseline. This indicates that K777 is a partial inhibitor of inflammasome activation induced 183 by PyV-derived VLPs. 184

Lysosomal damage can induce further processes which consolidate inflammasome 186 activation by VLPs as it was shown with inhaled particles, like silica and polystyrene 187 nanoparticles (Rabolli et al., 2016a) . The VLPs might also trigger different cell activation 188 pathways leading to inflammasome activation. To prove this assumption, we investigated an 189 alternative inflammasome activation pathway using K + efflux inhibitor, glybenclamide. This 190 inhibitor significantly blocked cell death according to LDH release data ( Fig 7A) . We also 191 observed a significant decrease in IL-1β release after glybenclamide pre-treatment ( Fig 7B) . 192 Taken together, these results reveal the complexity of inflammatory responses leading 193 to inflammasome activation induced by PyV-derived VLPs in THP-1 macrophages. It is 194

likely that several different mechanisms are involved in this process. 195

Inflammasome activation by PyV-derived VLPs was confirmed in primary human 196 macrophages 197

As cell lines may misrepresent real cell activation pattern, we used primary human 198 macrophages derived from monocytes of peripheral blood mononuclear cells to confirm cell 199 activation profile observed in THP-1 cells treated with PyV-derived VLPs. Activation of 200 primary human macrophages with VLPs revealed a similar cell activation pattern to that 201 observed in THP-1 macrophagesa significant increase in activated caspase-1 (Fig 8A and  202 B), cell death (Fig 8C) , and TNF-α and IL-1β release (Fig 8D and E) . Moreover, NLRP3 203 inflammasome inhibitor MCC950 significantly reduced primary human macrophage 204 activation and rescued from cell death (Fig 8A-C) . As in experiments with THP-1 205 macrophages, not all primary human macrophages were activated by the VLPs and the 206 percentage of dead cells did not exceed 20% (Figs 3E and 8C). According to FLICA assay 207

indicating caspase-1 activation (Fig 8A and B) , only a part of primary human macrophages 208 was activated by VLPs. According to PI staining, primary macrophages having activated 209 caspase-1 also were dead (Fig 8A) proving the pyroptotic cell death. These experiments 210

indicate a similar pattern of PyV VLP-induced inflammation followed by inflammasome 211 activation both in THP-1 cell line and in primary human macrophages. 212 We found that in some THP-1 cells the inflammasome is activated and in some is not 213

based on data obtained from caspase-1 and ASC speck formation assays. To identify 214 differences between these cells, we performed single-cell RNA sequencing (ScRNAseq) 215

analysis. This analysis was also used to reveal whether KIPyV and MCPyV VLPs induce 216 different cell activation states since we observed different cell activation levels according to 217 inflammatory cytokine production. 218

In vitro differentiated THP-1 macrophages were subjected to stimulation by VLPs of 220

KIPyV or MCPyV (and unstimulated control -PBS) for 15 h followed by single-cell 221 RNAseq (Fig 9A) . Upon removing transcriptomes with <900 total counts, 32,415 cells were 222 retained, with >10,000 cells per condition. The mitochondrial gene count filter, 223

conventionally used as a signature of dead cells (Luecken & Theis, 2019) , was omitted to 224 enable a comparison of the viability observed from scRNAseq data. 225

Uniform Manifold Approximation and Projection (UMAP) visualization of 226 scRNAseq data revealed an overall similar population structure between KIPyV and MCPyV 227 VLP treated cells, and an apparent difference compared to the unstimulated control ( Fig 9B) . 228

A bulk-like differential gene expression (DGE) analysis identified 43 upregulated and 12 229 downregulated genes in KIPyV VLP case vs the control ( Fig 9C and Table EV1 ). The 230 equivalent analysis of MCPyV VLP case vs control revealed 39 and 27 genes, respectively 231

By contrast, a total of 5 differentially-expressed genes (DEGs) were identified when 232

comparing MCPyV vs KIPyV VLP-treated cells. Most of the enriched genes compared to the 233 control were the same regardless of the VLPs used for stimulation, and the 5 most-enriched 234 terms in a GO gene set enrichment analysis of these common genes were associated with 235 immune cell activation processes (migration, chemotaxis, response to TNF and IL-1) ( Fig 9D  236 and EV9, Table EV2 ). 237

abundance upon VLP stimulation 239

The UMAP visualization of scRNAseq data revealed a continuous structure with no Table EV3 ), increases with 252 VLP stimulation from 2% to 5-6% ( Fig 10C) . 253

None of the states was completely quiescent, i.e., with all cells in the G0 stage, as 254 suggested by a classification into cell cycle stages based on gene expression, although 255 different populations showed a variable fraction of cells in G1/M/G2/S stages (Fig 10G) . 256

The cell cluster most uniformly represented across the three conditions (PBS, KIPyV 257

and MCPyV VLPs) was called steady state (SS) (Figs 10A and 10F ). Among its enriched 258 genes are CD52, LMO4, CHI3L1, COX5B (Figs. 10E and EV10Bb, Table EV3 ). The function 259 of most of proteins encoded by these genes is unclear. CD52 is a glycoprotein of an unknown 260 function. A recent study showed the ability of soluble CD52 to suppress inflammatory 261 cytokine production by inhibiting TLR-induced NF-κB activation in macrophages, 262 monocytes, and dendritic cells (Rashidi et al, 2018) . COX5B encodes 5B subunit of 263

Cytochrome C Oxidase, an essential mitochondrial respiratory chain enzyme (Galati et al, 264 2009 ). An increased expression of COX5B may be related to an increased cellular respiration. 265

LMO4-encoded protein may play a role as an oncogene targeting TGF-β signalling pathway 266 (Lu et al, 2006) . Overall, the phenotype of SS population is unclear as the functions of most 267 enriched genes in macrophages are unknown. In addition, GO enrichment analysis did not 268

show any relation to known GO terms ( Fig 10E) . Therefore, this population could be 269 described as a new possible phenotype of THP-1 cell line. 270

One cell cluster, the relative abundance of which changed upon cell activation, was 271 called resting state (RS) (Fig 10A) . This cell population did not express inflammatory 272 molecules and the enriched genes were related to usual cellular processes. cell adhesion, cell motility, and maintenance of cell shape (Hynes, 1986; Kornblihtt & 289 Gutman, 1988). Therefore, expression of these genes indicates restful cells. 290

Another cell cluster that changed upon cell activation was called metabolically active 291 (MA) ( Fig 10A) . It had a higher expression of mitochondrial and ribosomal genes, for 292 example, MT-CO3, MT-CYB, RPL37A, and RPS23 (Figs. 10E and EV10d). The MA cluster 293 did not show expression of genes related to inflammatory cell activation, but the observed 294 gene expression profile indicates increased cellular respiration that is related to high cell 295 metabolic activity (Osellame et al, 2012) . Enrichment in ribosomal genes characterized 296

protein production indicating metabolic cell activity. 297

In the control condition (PBS) we found a cluster in which the cells seemed to be 298 activated a priori. It was named prone to activation (PA) ( Fig 10A) . Higher expression of 299 SPP1, CTSC, TREM2, S100A4, and IL1B was detected in some cells of this cluster (Figs 10E,  300 EV10E and EV10F, Table EV3 ). It is possible that these cells showed a delayed response to 301 phorbol 12-myristate 13-acetate (PMA) used for THP-1 differentiation. This cell cluster 302 disappeared after treatment with VLPs. CTSC encodes lysosomal protease Cathepsin C. As 303 other cathepsins, CTSC is important for cargo degradation (Kominami et al, 1992) . CTSC 304 was also shown to be necessary for activating serine proteases since its absence altered 305 extracellular IL-1β activation mediated by serine proteases (Rabolli et al, 2016b cells are differently activated than other THP-1 cell populations (AI, AII, HA, IF) and they 319 distinguish themselves as having inflammation-related and phagocytic cell properties. 320

The cluster of cells formed upon VLP stimulation was defined as a high activation 321 (HA) state ( Fig 10A) . This cluster was more abundant in MCPyV VLP-treated cells than in 322

KIPyV VLP-treated cells ( Fig 10F) . This cell population was characterized with the highest 323 expression of IL1B and chemokine genes, such as CXCL1, CXCL3, CXCL8, CCL3, CCL20, 324 CCL4L2, and CSTB (Figs. 10E and EV10F, Table EV3 ). It is known that IL1B is expressed 325 at extremely high levels in myeloid-derived cells in response to microbial invasion and tissue 326

injury (Adamik et al, 2013) . The product of IL1B is pro-inflammatory cytokine IL-1β, a key 327 mediator of inflammation and one of the main indicators of NLRP3 inflammasome assembly 328 (Tominaga et al, 2000) . IL-1β induces the production of chemokines and proteases, such as 329 matrix metalloproteinase, to attract other immune cells to the infection site. Furthermore, 330

secretion of chemokines is reduced in NLRP3-deficient mice demonstrating the importance 331 of inflammasome activation in chemotaxis . IL-1β is a product of 332 inflammasome activation, thus, factors stimulating the inflammasome also recruit immune 333 cells. CXCL1, CXCL3, and CXCL8 encode members of the CXC subfamily of chemokines, 334 the chemoattractants for neutrophils (Raman et al, 2011) . CXCL8 also known as IL-8 has no 335 homologs in rats or mice and is a significant component of inflammation-mediated processes 336

as it attracts neutrophils, basophils, and T-cells to the site of infection and promotes 337 endothelial cell migration, invasion, and proliferation (Schutyser et al, 2002) . HA state is also 338 rich in genes of other chemoattractants CCL3 and CCL20. CCL3, also known as macrophage 339

inflammatory protein 1 alpha, is induced by NF-κB signalling pathway and triggers 340 inflammatory reactions (Cook, 1996) . CCL20 acts as a ligand for C-C chemokine receptor 341 CCR6 that induces a strong chemotactic response and plays an important role at skin and 342 mucosal surfaces under homeostatic and inflammatory conditions (Ito et al, 2011) . HA 343 cluster was also highly enriched in CSTB which encodes cystatin B, a cysteine protease 344

inhibitor known to interact with cathepsin B (Pavlova et al, 2000) and considered to protect 345 from cathepsin leakage from damaged lysosomes (Mrschtik & Ryan, 2015) . CSTB expression 346 reveals possible lysosomal damage induced by VLPs. Overall, highly enriched genes of HA 347 state showed a strong inflammatory response in VLP-treated macrophages. 348

Other cell clusters formed upon cell activation were named the Activation I (AI) and 349

Activation II (AII) states ( Fig 10A) . AI cluster was more characteristic for KIPyV than 350

MCPyV VLP-treated cells and AII state vice versa (Fig 10F) . Both clusters had enriched 351

inflammation-related genes similarly to HA state but at lower levels ( Fig 10E) oxidative stress and cell death as it is involved in decreasing peroxide formation from iron 382 (Mesquita et al, 2020) . In summary, HA and AII clusters next to inflammation-related genes 383 also expressed higher levels of genes encoding ion channels and proteins involved in 384 endocytosis contrary to AI state. abundance fold-change analysis emphasized the overall similar phenotype of the two VLP-391 treatment conditions (Fig 11D) , while abundance differences in abundance relatively to 392 control exceeded 30x (Fig 11E, F) . However, a notable exception was the interferon-response 393 population (IR), highly enriched after MCPyV VLP stimulation compared to KIPyV VLP 394 (Fig 11D) , and characterized by the expression of CXCL10, ISG15, IFITIM3, IFIT1-3, IFI6, 395 CXCL11 and other genes (Figs 10E and EV10H, Table EV3 ), known to be involved in 396

inhibition of viral invasion. Interestingly, we found an increase in interferon-inducible gene 397 expression only after treatment with MCPyV VLPs. We assume that macrophage 398 engagement with viral antigens itself mediates anti-viral activity in macrophages without 399 external stimulation, such as lipopolysaccharide. In addition, the expression of IR-specific 400 genes was essentially absent in control cells and after treatment with KIPyV VLPs (Fig  401  EV10B ). This suggests differences in pathogen-associated molecular patterns derived from 402 human PyVs. 403

In detail, most of IR cluster genes are induced by interferon (IFN) and related to cell 404

response during viral infection. IFITMs encode Interferon-Induced Transmembrane Proteins, 405

that limit viral infection via entry pathway (Zhao et al, 2018 For example, brain macrophages, microglia, are at different cell activation states depending 512 on the distance from amyloid-beta (Aβ) plaque in the brain of Alzheimer's disease patients 513 (Swanson et al, 2020) . Microglia with different phagocytic capabilities were also identified in 514

Alzheimer's disease-relevant mouse model. Interestingly, microglia non-containing Aβ had 515 more changes in expression of genes associated with accelerated ageing process than 516 microglia with Aβ content (Grubman et al, 2021 ). In addition, microglia are heterogeneous in 517 healthy brain and cells enriched in inflammation-related genes are present throughout the 518 lifespan and rises up in the aged brain (Hammond et al, 2019) . ScRNAseq analysis of 519 peripheral blood mononuclear cell culture revealed that monocytes respond differently to 520 lipopolysaccharide (Lawlor et al, 2021) . One cell population expressed pro-inflammatory 521 alarmins and chemokines to attract immune cells while another was enriched in later 522

inflammation-related and anti-inflammatory genes to either enhance or terminate 523 inflammatory reaction. In our study, IL-1β and TNF-α release data showed overall cell 524 activation by PyV-derived VLPs, however, caspase-1, ASC speck and cell viability assays 525 allowed the identification of differently activated cells. Therefore, we performed a single-cell 526 analysis to identify gene expression differences in cells which primarily were expected to be 527 homogenous -THP-1 cell culture model. 528

ScRNAseq analysis showed highly divergent cell activation pattern after treatment 529

with PyV-derived VLPs. Four activated THP-1 cell populations varying in expression of 530 inflammation-related genes, among them IL1B and chemokine genes, were identified. IL-1 531 family cytokines are known to induce the production of chemokines (Dinarello, 2018) . The 532 stress response and prolonged inflammation also lead to recruitment of immune cells (Carta 533 et al, 2017) . Therefore, increased chemokine expression in cells, enriched in IL-1β and other 534 inflammation mediators, indicates a strong inflammatory response. After VLP treatment, one 535 cell cluster was highly enriched in inflammation-related genes (HA state), including IL-1β. 536

This population was also enriched in CSTB which encodes cystatin B, an inhibitor of 537 cathepsin B. It possibly copes with cathepsins released after lysosomal leakage (Mrschtik & 538 Ryan, 2015). Therefore, CSTB expression verifies lysosomal damage induced by VLPs. This 539 cell cluster may represent a population of inflammasome-activated cells, which we revealed 540 according to ASC speck formation, cell viability and caspase-1 assays. 541

Interestingly, two populations of activated cells, including the HA cell cluster, also 542 expressed negative mediators of inflammation next to inflammation-related genes. This may 543 indicate a prolonged cell activation state when self-protecting genes were switched on to 544 avoid hyperinflammation. It is known that after inflammatory response follows the resolution 545 phase when anti-inflammatory molecules are secreted (Schett & Neurath, 2018) . 546

Comparing KIPyV and MCPyV VLP-induced cellular response, we found the 547 expression of interferon response-related genes only after MCPyV VLP treatment. This 548 extends known KIPyV and MCPyV differences. Among interferon-response genes were 549 CXCL10 and IGS15, involved in host antiviral response and found to induce cytokine storm 550

in SARS-CoV-2 infected patients (Callahan et al., 2021; Sanyal, 2020 Human cell line THP-1 monocytes -ASC speck reporter cells were purchased from 607

Invivogen (#thp-ascgfp, Invivogen, France) and called THP-1-ASC-GFP. These cells express 608 ASC protein fused to GFP. Cells were propagated in RPMI 1640 + 10% FBS + 100 U/mL of 609 P/S + 100 µg/ml of zeocin + 100 µg/ml normocin and were split twice a week by ratio 1:5 to 610 1:10. During cell differentiation to macrophages and treatment zeocin and normocin were not 611 used. 612

Human macrophage cell cultures were prepared by differentiation of THP-1 cells 614 (Chanput et al, 2014) . The cells were seeded in the 24 well plate at a density of 615 0.125x10 6 /well using RPMI 1640 medium supplemented with 10% FBS and 1% P/S and 616 differentiated to macrophages using 100 ng/mL of PMA. After 48 h of differentiation the 617 medium was replaced with the fresh medium without PMA and cells were left to rest for 618 another 24 h. After the rest period the cells are differentiated into macrophages and were used 619 in experiments with viral proteins. These macrophage-like cells were used in the study and 620 called THP-1 macrophages. 621

THP-1 macrophages were washed once with serum-free RPMI and treated with viral 622 proteins for 24 h. Viral proteins were prepared in PBS, so, control when PBS was added 623

instead of viral proteins was used. As a positive control, the inflammasome inducer nigericin 624 was used at 10 μM concentration. MCC950, which selectively inhibits the NLRP3 625 inflammasome, was used at 1 μM concentration and added 30 min before the treatment. 626

Inhibitors of cathepsins were used with the following concentrations: CA-074 Me at 2 μM 627 and 10 μM, K777 at 15 μM, and added 30 min before the treatment. Another inhibitor, 628 glybenclamide, which blocks K + efflux, was used at 50 µM concentration, 30 min before the 629 treatment. After incubation, cell culture supernatants were collected and stored at -20 °C for 630 further cytokine analysis. Supernatants for LDH assay were used instantly. 631

Primary human macrophages were purchased from Lonza (#4W-700). Human 632 macrophages were derived from CD14 + human monocytes of one donor. Cryopreserved cells 633

were thawed and cultured for two days in RPMI 1640 medium supplemented with 10% FBS 634 and 1% P/S before treatment. The cells were treated as THP-1 macrophages in serum-free 635 RPMI. Cells for FLICA assay were plated in Ibidi 96-well μ-plate and for ELISA in TPP 24-636 well plate. 637 and 0.001% Trition x-100 in 10 mM Tris/HCl-buffer, pH 7.2) and VLPs were concentrated 662 by ultracentrifugation at 100,000×g for 4 h (at 4 °C). Thereafter, pellets containing VP1 were 663 subjected to ultracentrifugation overnight on CsCl gradient (1.23-1.46 g/mL density) at 4 °C. 664

One millilitre fractions of formed gradient were collected and analysed by SDS-PAGE. 665

Positive fractions were pooled, diluted in DB150 buffer and concentrated as described above. 666

The isolated VLPs were dissolved in PBS, dialysed and stored in PBS with 50% glycerol. 667

The VLP formation was verified by examination of the purified proteins using Morgagni-268 668 electron microscope (FEI, Inc., Hillsboro, OR, USA). The protein samples were placed on 669 400-mesh carbon-coated palladium grids (Agar Scientific, Stansded, UK) and stained with 670 2% aqueous uranyl acetate. 671

Cell cytotoxicity was measured using lactate dehydrogenase (LDH) release assay 673 (LDH cytotoxicity detection Kit). A quantity of 50 μL of cell supernatants was used to 674 perform the cytotoxicity assay according to the manufacturer's protocol. Briefly, 50 μL of 675 supernatant was mixed with freshly prepared LDH reagent and incubated at 37 °C. After 30 676 min absorbance was measured at 490 nm using Multiskan GO microplate spectrophotometer 677 (Thermo Fisher Scientific Oy, Finland). 678

To determine cell viability PI/Hoechst nuclear staining was also used. Nuclei were 679 stained with 1.25 μg/ml PI and 1 μg/ml Hoechst33342 in cell culture medium for 30 min. 

To determine cleaved caspase-1 p20 fragment Western-blot assay (WB) was 716 performed. After cell treatment with viral proteins, supernatant was collected and centrifuged 717 at 600 × g for 10 min to remove cellular debris. Then, the protein content of the supernatants 718 was concentrated 10x using centrifugal filters with 10 kDa cutoff (#UFC501096, Amicon, 719

Merck was applied for 30 min followed by two washing steps. The primary antibodies rabbit 736 polyclonal anti-CD68 (1:100; #25747-1-AP, Proteintech) and mouse anti-PyV VP1 VLPs 737

(monoclonal antibodies of hybridoma supernatant at dilution 1:2) were added to the blocking 738 solution and incubated overnight. The following secondary antibodies were used 739 respectively: goat anti-rabbit (1:1000) and goat anti-mouse (1:1000). The secondary 740 antibodies were applied for 2 h followed by two washing steps. Hoechst33342 was used for 741 nuclear staining at 1 μg/mL for 30 min in PBS. The images were taken using a 40× objective. 742

CD68 was used as a macrophage and lysosomal marker. The experiment was imaged using 743 EVOS FL Auto fluorescence microscope (ThermoFisher Scientific, USA). Acquired images 744

were processed using ImageJ (Wayne Rusband; National Institute of Health, Bethesda, MD, 745 USA). 746

For the immunocytochemistry, in-house generated murine MAbs against recombinant 747

NLPs and VLPs were used (#MAb clonevirus antigen indicated): #7C11 -MeV N 748 (Zvirbliene et al., 2007) ScRNAseq count data analysis 803

Jupyter notebooks with commented code for scRNAseq data analyses, including data 804 filtering, normalization, visualization, clustering, cell population annotation, differential gene 805 expression (DGE) analysis, cell cycle scoring, and plots used in Figures 9-11 and EV9-11 are 806 provided on GitHub (github.com/rapolaszilionis/Luciunaite_et_al_2022). The Scanpy 807 toolbox was used for data analysis. Transcriptomes with fewer than 900 total counts were 808 excluded. No filtering on the fraction of mitochondrial counts was performed. UMAP (Becht 809 et al, 2018) was used for data visualization in 2D. Leiden clustering was used to divide the 810 graph into clusters, which were annotated based on their gene expression profiles. Gene 811

Ontology (GO) gene set enrichment analysis (Fig. 9D, 10E) All other data used to support the findings of this study are included within the article. 853 THP-1 macrophages were treated with recombinant viral proteins for 24 h at 20 µg/ml 1138 concentration. Cells were immunostained with anti-NLP and anti-VLP monoclonal 1139 antibodies (red), anti-CD68macrophage and lysosomal marker (green), nuclear stain 1140

Hoechst33342 (blue) and analysed by fluorescence microscopy. The negative control -1141 secondary antibody alone is referred as a control. Images were taken using 40× objective. 1142

The scale bars indicate 100 μm. All experiments were performed in triplicate. Representative 1143 images of one experiment are shown. 1144 Data information: Data are represented using box plots, *p < 0.05, **p < 0.01, ***p < 0.001, 1152 ****p < 0.0001, one-way ANOVA followed by Tukey's multiple comparison test, stars show 1153 statistically significant results compared to control. 1154 *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA followed by 1178

Tukey's multiple comparison test. For (C) and (D) N = 1. 1179 

Distinct 855 mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1β and tumor 856 necrosis factor α

Up-regulated cathepsin C induces 858 macrophage M1 polarization through FAK-triggered p38 MAPK/NF-κB pathway

ISG15 governs mitochondrial function in macrophages following vaccinia virus infection

Modulation of Immune Responses 863 by Particle Size and Shape

Dimensionality 865 reduction for visualizing single-cell data using UMAP

/CXCL10: structure and receptor interactions

A DAP12-mediated pathway regulates 869 expression of CC chemokine receptor 7 and maturation of human dendritic cells

The plasma membrane Ca²+ ATPase and the plasma membrane sodium calcium 871 exchanger cooperate in the regulation of cell calcium

Identification of a unique TGF-β-dependent molecular and functional signature in 874 microglia

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are

Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner

Macropinocytosis: New Insights Into Its Underappreciated Role in Innate Immune Cell 879 Surveillance

Sorting nexins--unifying trends and new perspectives

Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A 883 Matter of

Mammalian stanniocalcins and cancer

THP-1 cell line: An in vitro cell model for immune modulation 887 approach

Overexpression of TMEM158 contributes to ovarian 889 carcinogenesis

Emerging roles of FAM14 family members (G1P3/ISG 6-16 and 891

ISG12/IFI27) in innate immunity and cancer

Triggering of 893 inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

The role of MIP-1 alpha in inflammation and hematopoiesis

Activation of Macrophages by Oligomeric Proteins of 896 Different Size and Origin

Structure, interactions and self-assembly of ASC-dependent inflammasomes. Archives of 898

Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment 900

Overview of the IL-1 family in innate inflammation and acquired immunity

Macrophages Recognize Size and Shape of Their Targets

Innate immune activation 905 through Nalp3 inflammasome sensing of asbestos and silica

Interferon-induced Ifit proteins: their role in viral pathogenesis

The intra-and extracellular functions of ASC specks

Focus on the Role of NLRP3 Inflammasome 911 in Diseases

Role of nuclear-encoded subunit Vb in the assembly and stability of cytochrome c oxidase complex: 914 implications in mitochondrial dysfunction and ROS production

Cassatella 916 MA (1999) Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T 917 cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human 918 neutrophils

Coupling heme and iron metabolism via ferritin H chain

Landin 922 DV et al (2021) Transcriptional signature in microglia associated with Aβ plaque phagocytosis

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan

Injured Brain Reveals Complex Cell-State Changes

A link between inflammation and metastasis: serum amyloid A1 and 932 A3 induce metastasis, and are targets of metastasis-inducing S100A4

CEL-Seq: single-cell RNA-Seq by multiplexed linear 934 amplification

The metastasis associated protein S100A4: role in 936 tumour progression and metastasis

Silica 938 crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic 943 Implications

McManus 945 RM, Tejera D et al (2019) NLRP3 inflammasome activation drives tau pathology

CCR6 as a mediator of immunity in the lung 947 and gut

Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic 950 mouse model of Alzheimer's disease

The NLRP3 Inflammasome: An Overview of Mechanisms of 952 Activation and Regulation

Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells

TREM2/DAP12 Signal Elicits Proinflammatory 956 Response in Microglia and Exacerbates Neuropathic Pain

The primary structure and tissue distribution of cathepsin C

Molecular biology of the extracellular matrix proteins

Enhanced degradation of EGF receptors by a sorting nexin

Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS 965 or Anti-CD3 and Anti-CD28

Characterization of stanniocalcin-1 expression in macrophage differentiation

Silencing of TMEM158 Inhibits Tumorigenesis and Multidrug 969 Resistance in Colorectal Cancer

Cathepsin C 971 promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca

LMO4 can interact with Smad proteins and 974 modulate transforming growth factor-beta signaling in epithelial cells

A beta oligomers and protofibrils induce NLRP3 inflammasome activation in microglia

Current best practices in single-cell RNA-seq analysis: a tutorial

SARS-CoV-2 981 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage

ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, 984 and motility

Latent viral immune inflammatory response model for 986 chronic multisymptom illness

Tissue' transglutaminase ablation reduces neuronal death and prolongs survival 989 in a mouse model of Huntington's disease

Gomes MS 991 (2020) H-Ferritin is essential for macrophages' capacity to store or detoxify exogenously added iron

Lysosomal proteins in cell death and autophagy

Critical role for calcium 995 mobilization in activation of the NLRP3 inflammasome

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria

Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site 1001 required for infection

Karolinska Institutet and Washington University polyomaviruses

Production of recombinant 1005 VP1-derived virus-like particles from novel human polyomaviruses in yeast

Production of recombinant 1007 VP1-derived virus-like particles from novel human polyomaviruses in yeast

Macrophages in age-related chronic inflammatory diseases. Npj Aging and 1009 Mechanisms of Disease

Multiple Cathepsins Promote 1011 Pro-IL-1β Synthesis and NLRP3-Mediated IL-1β Activation

Cellular and molecular mechanisms of mitochondrial function

SARS-CoV-2 N 1015 protein promotes NLRP3 inflammasome activation to induce hyperinflammation

Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?

Cystatin inhibition of cathepsin B requires 1019 dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of 1020 his110

ISG15 in antiviral immunity and beyond

2021) α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary 1024 human microglia

A guide to vaccinology: from basic principles to new developments

The complex cascade of cellular events governing inflammasome 1028 activation and IL-1 beta processing in response to inhaled particles

The complex cascade of cellular events governing inflammasome 1030 activation and IL-1β processing in response to inhaled particles

Chemokines in health and disease

Laurent LC 1034 et al (2012) Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells

CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to 1038 suppress inflammation

Inflammasomes and Cell Death: Common Pathways in Microparticle 1040 Diseases

The Functional 1042 and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene

Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and 1046

High level expression of 1048 recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology

High level expression of 1051 recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology

Development of a measles specific IgM ELISA for use with serum and oral fluid samples 1055 using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae

How SARS-CoV-2 (COVID-19) spreads within infected hosts -what we know so far

TMEM119 marks a subset of 1060 microglia in the human brain

Resolution of chronic inflammatory disease: universal and tissue-specific 1062 concepts

Identification of biologically active chemokine isoforms from ascitic fluid 1065 and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma

Spatiotemporal proteomics uncovers cathepsin-dependent macrophage cell death during Salmonella 1069 infection

Opposing activities of IFITM proteins in SARS-CoV-2 infection

Pro-inflammatory role of NLRP3 inflammasome in experimental 1074 sterile corneal inflammation

Systematic Overview of Solid Particles and their Host Responses

Synthesis of the measles virus 1078 nucleoprotein in yeast Pichia pastoris and Saccharomyces cerevisiae

Macrophages and Iron Metabolism

IFITM3 1081 directly engages and shuttles incoming virus particles to lysosomes

Control of mitosis, inflammation, and cell motility by limited 1083 leakage of lysosomes

The NLRP3 inflammasome: molecular activation and regulation to 1085 therapeutics

Identification of a dysfunctional microglial population in human Alzheimer's disease cortex using novel 1088 single-cell histology image analysis

Clearance of apoptotic neurons without inflammation by 1090 microglial triggering receptor expressed on myeloid cells-2

synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells

Cutting edge: 1094 TREM-2 attenuates macrophage activation

Tuning Innate Immune 1096

Activation by Surface Texturing of Polymer Microparticles: The Role of Shape in Inflammasome Activation

Matrix metalloproteinase-8: cleavage can be decisive

Functional genomics reveals a family of eukaryotic oxidation 1101 protection genes

Loss of Oxidation Resistance 1, OXR1, Is Associated with an Autosomal-Recessive Neurological 1104 Disease with Cerebellar Atrophy and Lysosomal Dysfunction

The SNX-PX-BAR family in 1106 macropinocytosis: the regulation of macropinosome formation by SNX-PX-BAR proteins

Osteopontin: role in immune regulation and stress responses

Zika virus 1110 infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1 1111 beta secretion

SPRING: a kinetic interface for visualizing high dimensional single-1113 cell expression data

Novel Role of Matrix 1115

Metalloproteinase-8 in Macrophage Differentiation and Polarization

Inflammasome-Dependent and -Independent IL-18 Production Mediates Immunity to the 1118 ISCOMATRIX Adjuvant

ISG15 regulates peritoneal macrophages functionality against viral 1121 infection

Function of Macrophages in Disease: Current Understanding on 1123

IFITM Genes, Variants, and Their Roles in the Control and 1125 Pathogenesis of Viral Infections

Soluble 1127 TREM2 induces inflammatory responses and enhances microglial survival

Interferon induced IFIT family genes in 1129 host antiviral defense

Single-cell barcoding and 1131 sequencing using droplet microfluidics

Mapping of B cell epitopes in measles 1133 virus nucleocapsid protein

This study was supported by the Research Council of Lithuania, grant No. S-SEN-20-11. 831We would like to thank prof. L. Mažutis for cell line THP-1. 832 

Only expanded view tables uploaded as a separate file. 1270 1271